Financhill
Back

Rocket Pharmaceuticals Vs. Spyre Therapeutics Industry Stock Comparison

Sell
17

RCKT
Rocket Pharmaceuticals

Last Price:
$11.59
Seasonality Move:
-13.26%
Sell
28

SYRE
Spyre Therapeutics

Last Price:
$23.89
Seasonality Move:
27.42%
Sell
17
Rocket Pharmaceuticals (RCKT) is a Sell

Is Rocket Pharmaceuticals a Buy, Sell or Hold?

  • The current Rocket Pharmaceuticals [RCKT] share price is $11.58. The Score for RCKT is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
  • RCKT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
28
Spyre Therapeutics (SYRE) is a Sell

Is Spyre Therapeutics a Buy, Sell or Hold?

  • The current Spyre Therapeutics [SYRE] share price is $23.89. The Score for SYRE is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • SYRE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RCKT Stock Price Chart

What is Rocket Pharmaceuticals's stock price today?

  • The Rocket Pharmaceuticals share price today is $11.58
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RCKT is experiencing slight buying pressure.

SYRE Stock Price Chart

What is Spyre Therapeutics's stock price today?

  • The Spyre Therapeutics share price today is $23.89
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SYRE is experiencing slight buying pressure.

RCKT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.01 Sell
Relative Strength Index (14 RSI): 29.05 Sell
Chaikin Money Flow: 980346 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (12.26 - 14.14) Sell
Bollinger Bands (100): (14.41 - 19.73) Sell

SYRE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.84 Sell
Relative Strength Index (14 RSI): 36.71 Sell
Chaikin Money Flow: 155695 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (24.73 - 28.23) Sell
Bollinger Bands (100): (25.32 - 32.44) Sell

RCKT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.04 Sell
20-day SMA: 13.16 Sell
50-day SMA: 15.13 Sell
200-day SMA: 20.34 Sell
8-day EMA: 12.05 Sell
20-day EMA: 13 Sell
50-day EMA: 14.74 Sell
200-day EMA: 18.97 Sell

SYRE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.29 Sell
20-day SMA: 26.14 Sell
50-day SMA: 30.27 Sell
200-day SMA: 31.23 Sell
8-day EMA: 24.39 Sell
20-day EMA: 26.13 Sell
50-day EMA: 28.3 Sell
200-day EMA: 28.36 Sell

Rocket Pharmaceuticals Earnings Growth & RCKT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.17 per share, and an increase next year of $0.41 per share.

Spyre Therapeutics Earnings Growth & SYRE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $8.85 per share, and an increase next year of $0.14 per share.

Rocket Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Spyre Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):